Kisspeptin Dosage: What Studies Used
Why isn't a Kisspeptin dosage from a study advice?
The cancer team that found kisspeptin wanted to slow cancer spread. They weren't trying to set an amount for treatment. Later teams used it to watch the body's hormone chain.
Every figure here comes from closely watched work in people or animals. Kisspeptin has no FDA approval for medical use, so these figures aren't directions for you. The Kisspeptin dosage details tell you only what each study used.
What did Kisspeptin-10 do in men's vein studies?
These studies were short and closely watched, so they don't show what home use or your long-term care would do.
In 2011, healthy men received three rising amounts of KP-10 through a vein [5]. The hormone directing the testicles rose within minutes, and larger amounts brought larger rises. During a steady drip, that hormone and testosterone both rose [5].
Another KP-10 study included men who had mildly low testosterone along with type 2 diabetes. The first hormone rose about 2-fold. Testosterone returned to the usual range during the 11-hour test in 2013, and the response didn't fade during those hours [6].
How fast did Kisspeptin change the blood test?
The first hormone rose within minutes in the 2011 and 2013 studies [5][6]. KP-10 has a half-life of about 4 minutes, meaning half leaves the blood in that time.
An under-the-skin shot reaches the blood more slowly, and studies haven't set its exact start time. For you, how it was given changes what the timing means.
What did a Kisspeptin-54 drip do?
These studies included women no longer having periods because hormone messages from the brain had slowed.
In 2014, a steady KP-54 drip through a vein made the pulses about 3-fold more frequent and about 6-fold stronger [7]. The effect faded during the longer drip.
A 2009 study gave two KP-54 shots under the skin each day for 14 days [8]. On day 1, the hormone rose about 24 units in each liter of blood. By day 14, the rise was about 2.5 units per liter.
For you, this shows a brief response rather than a lasting result in your care.
What followed a Kisspeptin shot during IVF?
These IVF trials included women likely to have severe swelling of the ovaries, so the findings don't settle routine fertility care.
A 2015 Phase 2 trial, an early study in people, included 60 women. Each woman received one under-the-skin shot of KP-54 [9]. At the best amount tested, eggs matured in 95% of them, and the live birth rate was 62%. Researchers saw no critical cases, no severe cases, and no moderate cases.
An earlier 2014 study also used an under-the-skin shot of KP-54. Mature eggs, usable embryos, and pregnancies followed [10].
A 2017 study gave two KP-54 amounts to 62 women at high risk. More eggs matured without more swelling [11].
These results came from close care, so they aren't a personal dosing plan for you.
What did the 2025 Kisspeptin nose test find?
The first study in people to give KP-54 through the nose appeared in 2025 [21].
KP-54 raised the egg-release hormone in healthy women and men. That hormone also rose after the women's periods stopped, and researchers reported no bad events. The KP-54 liquid stayed usable for 60 days at 4 degrees C, which is refrigerator-cold.
The 2025 test showed that the nose route reached the hormone chain, but it didn't prove a benefit for your health.
There is a source-number mix-up. The nose study is marked [21] here, while the main list uses [21] for a different 2025 anxiety study. Both are separate studies, so use each study's name and year to tell them apart.
Kisspeptin half-life: How soon did blood levels fall?
These KP-10 and KP-54 figures tell you how quickly blood levels fell. They don't tell you when an effect would end. Half-life means the time until half remains.
KP-10. About half was gone in 4 minutes, with much the same time in men and women. After it entered a vein, KP-10 was gone by about 30 minutes [12].
KP-54. About half was gone in 27–32 minutes in people and about 32 minutes in mice [12]. Labs record the KP-54 weight as 6142 daltons, their unit for weighing very small things. You only need to know that it is larger. Its size may help KP-54 resist blood proteins that cut it, making its time about 8-fold longer.
Hormone effect in mice. At equal amounts, KP-54 kept the hormone raised for 1–4 hours, while KP-10 did so for 10–60 minutes [12]. These findings came from mice.
What is the Kisspeptin half-life in people?
About 4 minutes passed before half the KP-10 blood level remained, while KP-54 took about 27–32 minutes. Researchers used KP-10 for quick tests and KP-54 for IVF and missing-period studies [12].
Why did the long form keep working longer?
Blood proteins cut KP-54 more slowly. Its half-life was 8-fold longer, and its hormone rise lasted about 4x–6x longer than KP-10 at matched amounts [12].
For you, these times explain study choices rather than a schedule for use.
Kisspeptin side effects: What harm did studies find?
A 2025 systematic review documented no serious adverse events across more than 1,000 kisspeptin administrations across multiple research centers using IV and SC routes (Velmurugan 2025, Current Medicinal Chemistry) [22].
A 2025 randomized crossover trial in 95 participants specifically assessed whether kisspeptin-54 provoked anxiety. State anxiety, cortisol, and blood pressure were unchanged versus placebo despite confirmed biological activity (elevated LH) (JCEM, DOI 10.1210/clinem/dgaf128) [21].
The principal pharmacological concern documented in the literature is tachyphylaxis with chronic administration:
- Continuous high-dose IV infusion (1.0 nmol/kg/h) showed desensitization over prolonged administration in the Jayasena 2014 infusion study [7].
- Twice-daily SC injections for 14 days caused marked tachyphylaxis: LH response fell from approximately 24 IU/L on day 1 to approximately 2.5 IU/L by day 14 (Jayasena 2009, JCEM) [8].
This KISS1R desensitization pattern is the primary pharmacological limiting factor for sustained therapeutic use of kisspeptin, not an acute safety concern. Short-duration pulsatile protocols have been explored to mitigate receptor downregulation.
What happens if you take too much kisspeptin?
Continuous high-dose infusion in research settings produced receptor desensitization and paradoxical suppression of LH output — the tachyphylaxis documented in the Jayasena 2014 and Jayasena 2009 studies [7][8]. Pulsatile and intermittent protocols were explored specifically to preserve receptor sensitivity. No serious adverse events were reported in the clinical literature from any dose studied.
The trial record above does not determine whether kisspeptin suits an individual; mypromise.com is where Promise Peptides lists kisspeptin for prescription care. Each person's history goes to a licensed U.S. prescriber, who can issue a prescription or turn the request down. The service is for patients in the United States; their state and the treatment sought set further limits. Compounded kisspeptin has no FDA approval. FDA's Category 2 entry for kisspeptin-10 cites safety risks and excludes routine 503A compounding.
Why did repeated Kisspeptin lose strength?
The response faded with repeat or steady use. Two KP-54 shots under the skin each day for 14 days led to a 10-fold smaller hormone rise [8]. A steady drip also lost strength [7].
With a constant hormone message, the matching spot on the cell can answer less strongly. KP-10 has a 4-minute half-life, so researchers left breaks between amounts and let the cells respond again.
For you, this is a warning about a limit rather than a dosing idea. More or more often didn't bring a strong, lasting response.